Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics (NQ: AKBA )

1.480 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,148
Open 1.480
Bid (Size) 1.460 (16)
Ask (Size) 1.520 (7)
Prev. Close 1.480
Today's Range 1.480 - 1.480
52wk Range 0.7801 - 2.480
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024
AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Performance

YTD
+16.54%
+16.54%
1 Month
+72.76%
+72.76%
3 Month
+11.28%
+11.28%
6 Month
-1.33%
-1.33%
1 Year
+2.07%
+2.07%

More News

Read More
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Via MarketBeat
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Recap: Akebia Therapeutics Q4 Earnings
Via Benzinga
Earnings Preview For Akebia Therapeutics
Via Benzinga
Earnings Outlook For Akebia Therapeutics
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Akebia Therapeutics Inc. (NASDAQ: AKBA) is One of Thursday Morning’s Most Active Stocks
Via Investor Brand Network
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
Via Benzinga
Exposures Product Safety
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Via Benzinga
Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Earnings Scheduled For August 25, 2023
Via Benzinga
Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.